|
LOC550643 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.126400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.003900E-02 |
| Normal-vs-Stage2 |
5.505800E-02 |
| Normal-vs-Stage3 |
1.998970E-01 |
| Normal-vs-Stage4 |
3.591000E-01 |
| Stage1-vs-Stage2 |
5.185400E-01 |
| Stage1-vs-Stage3 |
5.141400E-01 |
| Stage1-vs-Stage4 |
5.858200E-03 |
| Stage2-vs-Stage3 |
2.800600E-01 |
| Stage2-vs-Stage4 |
1.385590E-02 |
| Stage3-vs-Stage4 |
5.480400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.517810E-01 |
| Normal-vs-AfricanAmerican |
5.095300E-03 |
| Normal-vs-Asian |
6.766600E-01 |
| Caucasian-vs-AfricanAmerican |
1.738090E-02 |
| Caucasian-vs-Asian |
4.240200E-01 |
| AfricanAmerican-vs-Asian |
1.174350E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.874000E-02 |
| Normal-vs-Female |
1.030750E-01 |
| Male-vs-Female |
3.296800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.962300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.372790E-01 |
| Normal-vs-Age(61-80Yrs) |
1.339370E-01 |
| Normal-vs-Age(81-100Yrs) |
6.323400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.151800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.624400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.660600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.246200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.515000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.383400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.69439999994936E-06 |
| Classical-VS-Follicular |
2.042000E-02 |
| Classical-VS-Other |
9.797200E-01 |
| Classical-VS-Normal |
1.244830E-01 |
| Tall-VS-Follicular |
6.51729999967543E-07 |
| Tall-VS-Other |
3.035800E-02 |
| Tall-VS-Normal |
1.203880E-02 |
| Follicular-VS-Other |
4.789800E-01 |
| Follicular-VS-Normal |
2.621900E-03 |
| Other-VS-Normal |
5.104000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.383100E-03 |
| Normal-vs-N1 |
3.767800E-01 |
| N0-vs-N1 |
7.999000E-04 |
|
|
